• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Pres., CEO & Executive Chair Dalton Travis bought $248,421 worth of shares (4,282 units at $58.02) (SEC Form 4)

    8/12/25 4:19:12 PM ET
    $CTEV
    Real Estate
    Real Estate
    Get the next $CTEV alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Dalton Travis

    (Last) (First) (Middle)
    C/O CLARITEV CORPORATION
    7900 TYSONS ONE PLACE, SUITE 400

    (Street)
    MCLEAN VA 22102

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Claritev Corp [ CTEV ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Pres., CEO & Executive Chair
    3. Date of Earliest Transaction (Month/Day/Year)
    08/08/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A common stock 08/08/2025 P 300 A $54.2083(1) 300 I Spouse's Individual Retirement Account
    Class A common stock 08/11/2025 P 3,982 A $58.3019(2) 4,282 I Spouse's Individual Retirement Account
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $54.18 to $54.25, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form-4.
    2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $58.06 to $58.5, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
    Remarks:
    /s/ Kent Bartholomew, attorney-in-fact 08/12/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CTEV alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CTEV

    DatePrice TargetRatingAnalyst
    10/21/2025$74.00Neutral → Buy
    Citigroup
    5/29/2025$44.00Neutral → Overweight
    Piper Sandler
    More analyst ratings

    $CTEV
    SEC Filings

    View All

    Claritev Corporation filed SEC Form 8-K: Other Events

    8-K - Claritev Corp (0001793229) (Filer)

    11/14/25 4:16:50 PM ET
    $CTEV
    Real Estate

    SEC Form 424B3 filed by Claritev Corporation

    424B3 - Claritev Corp (0001793229) (Filer)

    11/14/25 6:05:22 AM ET
    $CTEV
    Real Estate

    SEC Form 424B3 filed by Claritev Corporation

    424B3 - Claritev Corp (0001793229) (Filer)

    11/12/25 4:10:07 PM ET
    $CTEV
    Real Estate

    $CTEV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Pres., CEO & Executive Chair Dalton Travis bought $249,842 worth of shares (5,290 units at $47.23) (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    11/20/25 5:57:08 PM ET
    $CTEV
    Real Estate

    SVP, Chief Strategy Officer Mintz William B. bought $34,808 worth of shares (916 units at $38.00), increasing direct ownership by 1% to 65,325 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    11/19/25 4:34:04 PM ET
    $CTEV
    Real Estate

    EVP, Chief Digital Officer Kim Michael bought $367,199 worth of shares (9,600 units at $38.25), increasing direct ownership by 10% to 105,529 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    11/18/25 4:23:08 PM ET
    $CTEV
    Real Estate

    $CTEV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Claritev Corporation Announces Pricing of Offering of Class A Common Stock by Selling Stockholders

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the pricing of an underwritten public offering (the "Offering") of 1,500,000 shares of its Class A common stock, par value $0.0001 per share (the "Class A common stock"), by certain affiliates of Hellman & Friedman (collectively, the "Selling Stockholders") at a price to the public of $51.50 per share. The Selling Stockholders granted the underwriters a 30-day option to purchase up to an additional 225,000 shares of Class A common stock. The underwriters propose to offer the shares of Class A commo

    11/12/25 11:01:00 PM ET
    $CTEV
    Real Estate

    Claritev Corporation Announces Public Offering of Class A Common Stock by Selling Stockholders

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the commencement of an underwritten public offering (the "Offering") of 1,500,000 shares of its Class A common stock, par value $0.0001 per share (the "Class A common stock"), by certain affiliates of Hellman & Friedman (collectively, the "Selling Stockholders"). The Selling Stockholders granted the underwriters a 30-day option to purchase up to an additional 225,000 shares of Class A common stock. The underwriters propose to offer the shares of Class A common stock to the public at a fixed price,

    11/12/25 4:10:00 PM ET
    $CTEV
    Real Estate

    Claritev Corporation Reports Third Quarter 2025 Results

    – Q3 2025 Revenues of $246.0 million grew 6.7% compared to Q3 2024 – Net Loss of $69.8 million – Adjusted EBITDA of $155.1 million increased 9.5% compared to Q3 2024 (Adjusted EBITDA Margin of 63.1% versus 61.5% in Q3 2024) – Claritev raises full-year 2025 revenue and Adjusted EBITDA guidance Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the third quarter ended September 30, 2025. "We declared 2025 would be the Year of the Turn at Claritev. Our third quarter results and increased full year guidance demonstrate that w

    11/7/25 6:00:00 AM ET
    $CTEV
    Real Estate

    $CTEV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Claritev upgraded by Citigroup with a new price target

    Citigroup upgraded Claritev from Neutral to Buy and set a new price target of $74.00

    10/21/25 7:13:03 AM ET
    $CTEV
    Real Estate

    Claritev upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Claritev from Neutral to Overweight and set a new price target of $44.00

    5/29/25 8:13:13 AM ET
    $CTEV
    Real Estate

    $CTEV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Pres., CEO & Executive Chair Dalton Travis bought $249,842 worth of shares (5,290 units at $47.23) (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    11/20/25 5:57:08 PM ET
    $CTEV
    Real Estate

    SVP, Chief Strategy Officer Mintz William B. bought $34,808 worth of shares (916 units at $38.00), increasing direct ownership by 1% to 65,325 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    11/19/25 4:34:04 PM ET
    $CTEV
    Real Estate

    EVP, Chief Digital Officer Kim Michael bought $367,199 worth of shares (9,600 units at $38.25), increasing direct ownership by 10% to 105,529 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    11/18/25 4:23:08 PM ET
    $CTEV
    Real Estate

    $CTEV
    Leadership Updates

    Live Leadership Updates

    View All

    Claritev Releases 2024 Corporate Responsibility Report

    Third annual report highlights the company's commitment to social and environmental stewardship Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the publication of its 2024 Corporate Responsibility Report. The 2024 report showcases the Company's strategic momentum in advancing its sustainability priorities during a pivotal year of transformation. The report emphasizes Claritev's continued focus on managing, tracking and disclosing its social and environmental performance, reinforcing its commitment to accountability and responsible

    7/16/25 9:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Appoints Mohamed Ramzy as SVP and General Manager, International to Lead Geographic Expansion; Signs with Halian to Support Regional Operations

    Strategic leadership and operational collaboration underscore Claritev's commitment to growth in the Middle East and international business development outside the US Claritev Corporation ("Claritev") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced it is deepening its investment in the Middle East North Africa ("MENA") region and the market outside the United States with the appointment of new regional leadership and a strategic operational collaboration. These moves reflect Claritev's continued focus on expanding its footprint and delivering localized, high-impact healthcare technology soluti

    5/28/25 8:00:00 AM ET
    $CTEV
    Real Estate

    Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks

    HOLLYWOOD, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Great Speech, a national leader in virtual speech therapy, is proud to announce a new agreement with Claritev, formerly known as MultiPlan (NYSE:CTEV), a technology and data insights company focused on making healthcare more affordable, transparent and fair for all. This network participation agreement marks a major step forward in expanding access to high-quality, convenient, and personalized speech therapy services for individuals and families nationwide. Great Speech's innovative teletherapy services will now be available to health plan members accessing Claritev's MultiPlan and PHCS Networks. The initiative aims to eliminate traditio

    5/6/25 10:02:00 AM ET
    $CTEV
    Real Estate

    $CTEV
    Financials

    Live finance-specific insights

    View All

    Claritev Corporation Reports Third Quarter 2025 Results

    – Q3 2025 Revenues of $246.0 million grew 6.7% compared to Q3 2024 – Net Loss of $69.8 million – Adjusted EBITDA of $155.1 million increased 9.5% compared to Q3 2024 (Adjusted EBITDA Margin of 63.1% versus 61.5% in Q3 2024) – Claritev raises full-year 2025 revenue and Adjusted EBITDA guidance Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the third quarter ended September 30, 2025. "We declared 2025 would be the Year of the Turn at Claritev. Our third quarter results and increased full year guidance demonstrate that w

    11/7/25 6:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Corporation Announces Third Quarter 2025 Earnings Conference Call

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its third quarter 2025 financial results on Friday, November 7, 2025, and hold its conference call that morning at 8:00 am Eastern Time. To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique PIN. Pre-registration may be completed at any time up to and following the call start time. To pre-register, go to the following link: https://www.net

    10/16/25 7:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Corporation Reports Second Quarter 2025 Results

    Q2 2025 Revenues of $241.6 million, Net Loss of $62.6 million, and Adjusted EBITDA of $154.0 million (Adjusted EBITDA Margin of 63.8%) Full-year 2025 guidance updates to Revenue range (flat to +2% vs. 2024), Free Cash Flow range (usage of $20 million to generation of $20 million for year) and Capital Expenditures ($170 million to $180 million for year) Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the second quarter ended June 30, 2025. "Claritev is truly delivering in the year of The Turn. We returned to growth m

    8/6/25 6:00:00 AM ET
    $CTEV
    Real Estate